al-Mahdawi S, Chamberlain S, Cleland J, Nihoyannopoulos P, Gilligan D, French J, Choudhury L, Williamson R, Oakley C
Department of Biochemistry and Molecular Genetics, St Mary's Hospital Medical School, Imperial College, London.
Br Heart J. 1993 Feb;69(2):136-41. doi: 10.1136/hrt.69.2.136.
To investigate the molecular genetic basis of the cause of disease in a family with hypertrophic cardiomyopathy.
Mutation within the beta cardiac myosin heavy chain gene has been shown to be the pathogenetic mechanism underlying the disease in several families, though clear evidence of heterogeneity has been reported.
A family with a history of hypertrophic cardiomyopathy.
This paper reports a mutation at aminoacid position 908 within exon 23 of the beta cardiac myosin heavy chain gene, resulting in a conversion of a leucine to valine. This base substitution was identified in an individual with a confirmed family history but with equivocal symptoms of the disease. Inheritance of the mutation by his symptom free juvenile offspring demonstrates the application of the technique to presymptomatic diagnosis.
研究一个肥厚型心肌病家族的致病分子遗传学基础。
β心肌肌球蛋白重链基因内的突变已被证明是几个家族中该疾病的致病机制,尽管已有异质性的明确证据报道。
一个有肥厚型心肌病家族史的家族。
本文报道了β心肌肌球蛋白重链基因第23外显子第908位氨基酸处的一个突变,导致亮氨酸转变为缬氨酸。在一名有确诊家族史但症状不明确的个体中发现了这种碱基替换。他无症状的青少年后代遗传了该突变,证明了该技术在症状前诊断中的应用。